# MIRABEGRON
> **ANDA217989** · Abbreviated New Drug Application (Generic) · Sponsor: QILU · Approved 2025-06-30
## Drug
- **FDA Application Number:** ANDA217989
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MIRABEGRON
- **Generic name:** MIRABEGRON
- **Active ingredients:** MIRABEGRON
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** QILU
- **Manufacturer:** Qilu Pharmaceutical Co., Ltd.
- **First approval:** 2025-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217989)
---
*AI Analytics · CC0 1.0*